Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2615)
All Articles published online
|
Oct 1, 2004 (publication date) through May 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ichikawa H, Yoshida N, Takagi T, Tomatsuri N, Katada K, Isozaki Y, Uchiyama K, Naito Y, Okanoue T, Yoshikawa T. Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. World J Gastroenterol 2004; 10(19): 2814-2817 [PMID: 15334676 DOI: 10.3748/wjg.v10.i19.2814] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i19/2814.htm |
| Number | Citing Articles |
| 1 |
Yuji Naito. Anti-Inflammatory and Anti-Oxidative Properties of Proton Pump Inhibitors. Journal of Clinical Biochemistry and Nutrition 2007; 41(2): 82 doi: 10.3164/jcbn.2007011
|
| 2 |
Wengen Zhu, Kui Hong. Potential Cardiovascular Risks of Proton Pump Inhibitors in the General Population. International Heart Journal 2017; 58(2): 163 doi: 10.1536/ihj.16-208
|
| 3 |
Changjun Gao, Lixian Xu, Wei Chai, Xude Sun, Hui Zhang, Guihe Zhang. Amelioration of Intestinal Ischemia–Reperfusion Injury with Intraluminal Hyperoxygenated Solution: Studies on Structural and Functional Changes of Enterocyte Mitochondria1. Journal of Surgical Research 2005; 129(2): 298 doi: 10.1016/j.jss.2005.06.022
|
| 4 |
Petros Kopterides, Jeremy Kahn. Histamine-2 receptor antagonists versus proton pump inhibitors for stress ulcer prophylaxis in the ICU. F1000Research 2015; 4: 1291 doi: 10.12688/f1000research.6813.1
|
| 5 |
Sadayuki Hashioka, Andis Klegeris, Patrick L. McGeer. Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity. Experimental Neurology 2009; 217(1): 177 doi: 10.1016/j.expneurol.2009.02.002
|
| 6 |
Rupinder Kaur, Rupinder Kaur Sodhi, Neha Aggarwal, Jaspreet Kaur, Upendra K. Jain. Renoprotective effect of lansoprazole in streptozotocin-induced diabetic nephropathy in wistar rats. Naunyn-Schmiedeberg's Archives of Pharmacology 2016; 389(1): 73 doi: 10.1007/s00210-015-1182-6
|
| 7 |
Tomohisa Takagi, Yuji Naito, Toshikazu Yoshikawa. The Expression of Heme Oxygenase-1 Induced by Lansoprazole. Journal of Clinical Biochemistry and Nutrition 2009; 45(1): 9 doi: 10.3164/jcbn.SR09-28
|
| 8 |
Kazuhide Higuchi, Yukiko Yoda, Kikuko Amagase, Shinichi Kato, Satoshi Tokioka, Mitsuyuki Murano, Koji Takeuchi, Eiji Umegaki. Prevention of NSAID-Induced Small Intestinal Mucosal Injury: Prophylactic Potential of Lansoprazole. Journal of Clinical Biochemistry and Nutrition 2009; 45(2): 125 doi: 10.3164/jcbn.SR09-58
|
| 9 |
Cristina Pozzoli, Alessandro Menozzi, Daniela Grandi, Elvira Solenghi, Maria C. Ossiprandi, Chiara Zullian, Simone Bertini, Giulia M. Cavestro, Gabriella Coruzzi. Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine. Naunyn-Schmiedeberg's Archives of Pharmacology 2007; 374(4): 283 doi: 10.1007/s00210-006-0121-y
|
| 10 |
Norimasa Yoshida. Inflammation and Oxidative Stress in Gastroesophageal Reflux Disease. Journal of Clinical Biochemistry and Nutrition 2007; 40(1): 13 doi: 10.3164/jcbn.40.13
|
| 11 |
Tejal Gandhi, Anish Sharma, Navdha Vyas, Parth Gupta, Mihir Parikh, Hital Shah. Lansoprazole a Proton Pump Inhibitor Prevents IBD by Reduction of Oxidative Stress and NO Levels in the Rat. Drug Research 2021; 71(07): 379 doi: 10.1055/a-1389-5499
|
| 12 |
Yoichi Saegusa, Takafumi Ichikawa, Tomohisa Iwai, Yukinobu Goso, Tomoaki Ikezawa, Motoko Nakano, Nobuaki Shikama, Katsunori Saigenji, Kazuhiko Ishihara. Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis. Scandinavian Journal of Gastroenterology 2008; 43(5): 531 doi: 10.1080/00365520701811693
|
| 13 |
Toshikazu Yoshikawa. Proteome Analyse of Stress Responses in the Digestive Tract.. Nihon Naika Gakkai Zasshi 2010; 99(10): 2548 doi: 10.2169/naika.99.2548
|
| 14 |
Parichehr Kohansal, Nazanin Rajai, Ahmad Reza Dehpour, Amir Rashidian, Hamed Shafaroodi. The protective effect of acute pantoprazole pretreatment on renal ischemia/reperfusion injury in rats. Fundamental & Clinical Pharmacology 2019; 33(4): 405 doi: 10.1111/fcp.12451
|
| 15 |
Tomohisa Takagi, Yuji Naito, Hitomi Okada, Takeshi Ishii, Katsura Mizushima, Satomi Akagiri, Satoko Adachi, Osamu Handa, Satoshi Kokura, Hiroshi Ichikawa, Ken Itoh, Masayuki Yamamoto, Hirofumi Matsui, Toshikazu Yoshikawa. Lansoprazole, a Proton Pump Inhibitor, Mediates Anti-Inflammatory Effect in Gastric Mucosal Cells through the Induction of Heme Oxygenase-1 via Activation of NF-E2-Related Factor 2 and Oxidation of Kelch-Like ECH-Associating Protein 1. Journal of Pharmacology and Experimental Therapeutics 2009; 331(1): 255 doi: 10.1124/jpet.109.152702
|
| 16 |
David Lundgren, Vincy Eklöf, Richard Palmqvist, Johan Hultdin, Pontus Karling. Proton pump inhibitor use is associated with elevated faecal calprotectin levels. A cross-sectional study on subjects referred for colonoscopy. Scandinavian Journal of Gastroenterology 2019; 54(2): 152 doi: 10.1080/00365521.2019.1566493
|
| 17 |
Changjun Gao, Wei Chai, Lixian Xu, Guihe Zhang, Hui Zhang, Lichun Han, Xude Sun. Protective Effects of Hyperoxygenated Solution Preconditioning on Intestinal Ischemia–Reperfusion Injury in Rabbits. Journal of Surgical Research 2006; 135(2): 268 doi: 10.1016/j.jss.2006.03.019
|
| 18 |
Tetsuya Tanigawa, Toshio Watanabe, Kazuhide Higuchi, Hirohisa Machida, Hirotoshi Okazaki, Hirokazu Yamagami, Kenji Watanabe, Kazunari Tominaga, Yasuhiro Fujiwara, Nobuhide Oshitani, Tetsuo Arakawa. Lansoprazole, a Proton Pump Inhibitor, Suppresses Production of Tumor Necrosis Factor-α and Interleukin-1β Induced by Lipopolysaccharide and Helicobacter Pylori Bacterial Components in Human Monocytic Cells via Inhibition of Activation of Nuclear Factor-κB and Extracellular Signal-Regulated Kinase. Journal of Clinical Biochemistry and Nutrition 2009; 45(1): 86 doi: 10.3164/jcbn.08-267
|
| 19 |
Fares E.M. Ali, Emad H.M. Hassanein, Ali H. El-Bahrawy, Mohamed S. Hemeda, Ahmed M. Atwa. Neuroprotective effect of lansoprazole against cisplatin-induced brain toxicity: Role of Nrf2/ARE and Akt/P53 signaling pathways. Journal of Chemical Neuroanatomy 2023; 132: 102299 doi: 10.1016/j.jchemneu.2023.102299
|
| 20 |
Farshid Rahimi Bashar, Zahra Doosti, Arezoo Chouhdari, Shervin Shokouhi, Saadat Torabian, Zahra Sahraei, Seyed Pouzhia Shojaei, Mohammad Fathi, Reza Goharani, Mohammadreza Hajiesmaeili. Bacteriologic Evaluation of Ventilator-Associated Pneumonia According to Stress Related Mucosal Disease Prophylaxis in the Intensive Care Unit. Archives of Clinical Infectious Diseases 2018; 13(6) doi: 10.5812/archcid.82521
|
| 21 |
Ramalinga R. Kedika, Rhonda F. Souza, Stuart Jon Spechler. Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical Implications. Digestive Diseases and Sciences 2009; 54(11): 2312 doi: 10.1007/s10620-009-0951-9
|
| 22 |
Tiziana Larussa, Evelina Suraci, Isabella Leone, Immacolata Nazionale, Ludovico Abenavoli, Olimpio Galasso, Andrea Amorosi, Maria Imeneo, Francesco Luzza. Short‐term Therapy with Celecoxib and Lansoprazole Modulates Th1/ Th2 Immune Response in Human Gastric Mucosa. Helicobacter 2010; 15(5): 449 doi: 10.1111/j.1523-5378.2010.00796.x
|
| 23 |
Kun Lin, Xinpei Chen, Li Zhang, Yutang Wang, Zhaoliang Shan. Proton pump inhibitors as also inhibitors of atrial fibrillation. European Journal of Pharmacology 2013; 718(1-3): 435 doi: 10.1016/j.ejphar.2013.07.043
|
| 24 |
Osamu Handa, Yuji Naito, Toshikazu Yoshikawa. Rat Cytokine-Induced Neutrophil Chemoattractant-1 (CINC-1) in Inflammation. Journal of Clinical Biochemistry and Nutrition 2006; 38(2): 51 doi: 10.3164/jcbn.38.51
|